Mutations in BRCA1 and BRCA2 genes are strong risk indicators for breast and ovarian cancer.

According to the CDC, BRCA1 and BRCA2 mutations together account for 20% to 25% of hereditary breast cancers.

Our hereditary cancer genetic screening will test for changes in both BRCA1 and BRCA2 and 30 additional genes to inform you about risks associated with breast, ovarian, colon, and endometrial (uterine) cancers.